DK2717940T3 - Behandling af tilstande associeret med metabolisk syndrom - Google Patents

Behandling af tilstande associeret med metabolisk syndrom Download PDF

Info

Publication number
DK2717940T3
DK2717940T3 DK12727914.9T DK12727914T DK2717940T3 DK 2717940 T3 DK2717940 T3 DK 2717940T3 DK 12727914 T DK12727914 T DK 12727914T DK 2717940 T3 DK2717940 T3 DK 2717940T3
Authority
DK
Denmark
Prior art keywords
treatment
metabolic syndrome
conditions associated
metabolic
syndrome
Prior art date
Application number
DK12727914.9T
Other languages
English (en)
Inventor
Graham Cotton
Ola Winqvist
Original Assignee
Tla Targeted Immunotherapies Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tla Targeted Immunotherapies Ab filed Critical Tla Targeted Immunotherapies Ab
Application granted granted Critical
Publication of DK2717940T3 publication Critical patent/DK2717940T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
    • B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
    • B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
DK12727914.9T 2011-06-13 2012-06-13 Behandling af tilstande associeret med metabolisk syndrom DK2717940T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496167P 2011-06-13 2011-06-13
PCT/GB2012/051349 WO2013041833A1 (en) 2011-06-13 2012-06-13 Treating conditions associated with metabolic syndrome

Publications (1)

Publication Number Publication Date
DK2717940T3 true DK2717940T3 (da) 2020-07-13

Family

ID=46317435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12727914.9T DK2717940T3 (da) 2011-06-13 2012-06-13 Behandling af tilstande associeret med metabolisk syndrom

Country Status (5)

Country Link
EP (1) EP2717940B1 (da)
CN (1) CN103796693B (da)
DK (1) DK2717940T3 (da)
ES (1) ES2801901T3 (da)
WO (1) WO2013041833A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163635A (zh) * 1995-06-07 1997-10-29 艾科斯有限公司 巨噬细胞来源的趋化因子和趋化因子类似物
WO2000050088A2 (en) 1999-02-22 2000-08-31 Millennium Pharmaceuticals, Inc. Biotinylated-chemokine antibody complexes
US6964967B2 (en) * 2000-12-11 2005-11-15 Amgen, Inc. Substituted pyrido[2,3-d]pyrimidines and methods for their use
KR101398768B1 (ko) * 2006-09-29 2014-05-27 도레이 카부시키가이샤 세포 흡착 컬럼
WO2010021697A2 (en) 2008-08-18 2010-02-25 Pfizer Inc. Antibodies to ccr2
KR101703785B1 (ko) * 2008-09-10 2017-02-07 아이티에이치 임뮨 세라피 홀딩스 에이비 염증 증상의 치료 방법

Also Published As

Publication number Publication date
CN103796693B (zh) 2017-05-31
WO2013041833A1 (en) 2013-03-28
ES2801901T3 (es) 2021-01-14
EP2717940B1 (en) 2020-04-22
CN103796693A (zh) 2014-05-14
EP2717940A1 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
DK3501549T3 (da) Behandling af amd med aav sflt-1
DK3235812T3 (da) Deutererede derivater af ivacaftor
HK1204272A1 (en) Methods of treating pediatric metabolic syndrome
DK2906698T3 (da) Fremgangsmåde til behandling af alports syndrom
CO7010824A2 (es) Inhibidores de aplicación viral
DK2734126T3 (da) Medicinske anordninger med aftagelige drejelige kæber
DK2694810T4 (da) Vindmølle med direkte drev
DK2785349T3 (da) Kombinationsbehandling af cancer
DK2846809T3 (da) Behandling af myelosuppression
DK2717941T3 (da) Behandling af cancer
DK2603226T3 (da) Behandling af diabetes med endokrine pankreas-prækursorceller
DK2828208T3 (da) Aktivering af persulfater med organisk syre
DK2723347T3 (da) Forebyggelse og behandling af inflammationstilstande
BR112014013850A2 (pt) conjunto de prateleiras
DK2706977T3 (da) Dispergeringsmidler med biobaserede forbindelser
DK3581199T3 (da) Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis
DK2782565T3 (da) Anvendelse af aryl- og hetarylcarboxamider som endoparasiticider
DK2760629T3 (da) Konstruktion med kegleformet struktur
DK3456333T3 (da) Anvendelse af telomeraseinhibitor imetelstat til behandling af myelodysplastisk syndrom
DK3132684T3 (da) Behandling af fiskepopulationer med lufenuron
DK2673363T3 (da) Behandling af angiogenesesygdomme
DK2838850T3 (da) Oprensning af titantetrachlorid
DK2916922T3 (da) Behandling af alkalisk bauxitrest
DK2852633T3 (da) Anvendelse af en genstand med variabel tg
DK3329927T3 (da) IBS-behandling med probiotika